Microarray Analysis of the Df1 Mouse Model of the 22q11 Deletion Syndrome

Overview

Journal Hum Genet

Specialty Genetics

Date 2005 Mar 22

PMID 15778864

Citations 17

Authors

Katrina Prescott

Sarah Ivins

Mike Hubank

Elizabeth Lindsay

Antonio Baldini

Peter Scambler

Affiliations

Soon will be listed here.

Abstract

The 22q11 deletion syndrome (22q11DS; DiGeorge/velo-cardio-facial syndrome) primarily affects the structures comprising the pharyngeal arches and pouches resulting in arch artery, cardiac, parathyroid, thymus, palatal and craniofacial defects. Tbx1 haploinsufficiency is thought to account for the main structural anomalies observed in the 22q11DS. The Df1 deleted mouse provides a model for 22q11DS, the deletion reflecting Tbx1 haploinsufficiency in the context of the deletion of 21 adjacent genes. We examined the expression of genes in Df1 embryos at embryonic day (E) 10.5, a stage when the arch-artery phenotype is fully penetrant. Our aims were threefold, with our primary aim to identify differentially regulated genes. Second, we asked whether any of the genes hemizygous in Df1 were dosage compensated to wild type levels, and third we investigated whether genes immediately adjacent to the deletion were dysregulated secondary to a position effect. Utilisation of oligonulceotide arrays allowed us to achieve our aims with 9 out of 12 Df1 deleted genes passing the stringent statistical filtering applied. Several genes involved in vasculogenesis and cardiogenesis were validated by real time quantitative PCR (RTQPCR), including Connexin 45, a gene required for normal vascular development, and Dnajb9 a gene implicated in microvascular differentiation. There was no evidence of any dosage compensation of deleted genes, suggesting this phenomenon is rare, and no dysregulation of genes mapping immediately adjacent to the deletion was detected. However Crkl, another gene implicated in the 22q11DS phenotype, was found to be downregulated by microarray and RTQPCR.

Citing Articles

Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome.

Bhalla P, Du Q, Kumar A, Xing C, Moses A, Dozmorov I J Clin Invest. 2022; 132(22).

PMID: 36136514 PMC: 9663160. DOI: 10.1172/JCI160101.

The function of the co-chaperone ERdj4 in diverse (patho-)physiological conditions.

Daverkausen-Fischer L, Prols F Cell Mol Life Sci. 2021; 79(1):9.

PMID: 34950970 PMC: 8702508. DOI: 10.1007/s00018-021-04082-4.

Disruption of the blood-brain barrier in 22q11.2 deletion syndrome.

Crockett A, Ryan S, Vasquez A, Canning C, Kanyuch N, Kebir H Brain. 2021; 144(5):1351-1360.

PMID: 33876226 PMC: 8219368. DOI: 10.1093/brain/awab055.

Cardiac Neural Crest Cells: Their Rhombomeric Specification, Migration, and Association with Heart and Great Vessel Anomalies.

Schussler O, Gharibeh L, Mootoosamy P, Murith N, Tien V, Rougemont A Cell Mol Neurobiol. 2020; 41(3):403-429.

PMID: 32405705 PMC: 11448677. DOI: 10.1007/s10571-020-00863-w.

Downregulation of genes outside the deleted region in individuals with 22q11.2 deletion syndrome.

Dantas A, Santoro M, Nunes N, Mello C, Pimenta L, Ayres Meloni V Hum Genet. 2019; 138(1):93-103.

PMID: 30627818 DOI: 10.1007/s00439-018-01967-6.

References

Ataliotis P, Ivins S, Mohun T, Scambler P . XTbx1 is a transcriptional activator involved in head and pharyngeal arch development in Xenopus laevis. Dev Dyn. 2005; 232(4):979-91. DOI: 10.1002/dvdy.20276. View

Pfeifer D, Kist R, Dewar K, Devon K, Lander E, Birren B . Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am J Hum Genet. 1999; 65(1):111-24. PMC: 1378081. DOI: 10.1086/302455. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Kruger O, Plum A, Kim J, Winterhager E, Maxeiner S, Hallas G . Defective vascular development in connexin 45-deficient mice. Development. 2000; 127(19):4179-93. DOI: 10.1242/dev.127.19.4179. View

Sock E, Rettig S, Enderich J, Bosl M, Tamm E, Wegner M . Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol Cell Biol. 2004; 24(15):6635-44. PMC: 444853. DOI: 10.1128/MCB.24.15.6635-6644.2004. View

Vitelli F, Taddei I, Morishima M, Meyers E, Lindsay E, Baldini A . A genetic link between Tbx1 and fibroblast growth factor signaling. Development. 2002; 129(19):4605-11. DOI: 10.1242/dev.129.19.4605. View

Hu T, Yamagishi H, Maeda J, McAnally J, Yamagishi C, Srivastava D . Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development. 2004; 131(21):5491-502. DOI: 10.1242/dev.01399. View

Novelli G, Amati F, Dallapiccola B . Individual haploinsufficient loci and the complex phenotype of DiGeorge syndrome. Mol Med Today. 2000; 6(1):10-1. DOI: 10.1016/s1357-4310(99)01577-4. View

Guris D, Fantes J, Tara D, Druker B, Imamoto A . Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet. 2001; 27(3):293-8. DOI: 10.1038/85855. View

10.

Saran N, Pletcher M, Natale J, Cheng Y, Reeves R . Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum Mol Genet. 2003; 12(16):2013-9. DOI: 10.1093/hmg/ddg217. View

11.

Prols F, Mayer M, Renner O, Czarnecki P, Ast M, Gassler C . Upregulation of the cochaperone Mdg1 in endothelial cells is induced by stress and during in vitro angiogenesis. Exp Cell Res. 2001; 269(1):42-53. DOI: 10.1006/excr.2001.5294. View

12.

Guidi C, Veal T, Jones S, Imbalzano A . Transcriptional compensation for loss of an allele of the Ini1 tumor suppressor. J Biol Chem. 2003; 279(6):4180-5. DOI: 10.1074/jbc.M312043200. View

13.

Lindsay E, Botta A, Jurecic V, Cheah Y, Rosenblatt H, Bradley A . Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature. 1999; 401(6751):379-83. DOI: 10.1038/43900. View

14.

Lindsay E, Baldini A . Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region. Hum Mol Genet. 2001; 10(9):997-1002. DOI: 10.1093/hmg/10.9.997. View

15.

Xu H, Morishima M, Wylie J, Schwartz R, Bruneau B, Lindsay E . Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development. 2004; 131(13):3217-27. DOI: 10.1242/dev.01174. View

16.

Chiang P, Kurnit D . Study of dosage compensation in Drosophila. Genetics. 2003; 165(3):1167-81. PMC: 1462830. DOI: 10.1093/genetics/165.3.1167. View

17.

Kleinjan D, Seawright A, Schedl A, Quinlan R, Danes S, Van Heyningen V . Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6. Hum Mol Genet. 2001; 10(19):2049-59. DOI: 10.1093/hmg/10.19.2049. View

18.

Kumai M, Nishii K, Nakamura K, Takeda N, Suzuki M, Shibata Y . Loss of connexin45 causes a cushion defect in early cardiogenesis. Development. 2000; 127(16):3501-12. DOI: 10.1242/dev.127.16.3501. View

19.

Bruneau B, Nemer G, Schmitt J, Charron F, Robitaille L, Caron S . A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001; 106(6):709-21. DOI: 10.1016/s0092-8674(01)00493-7. View

20.

Vitelli F, Morishima M, Taddei I, Lindsay E, Baldini A . Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum Mol Genet. 2002; 11(8):915-22. DOI: 10.1093/hmg/11.8.915. View